Key result
Pharmacological or siRNA-mediated inhibition of FAK significantly reduced oligomycin- and insulin-stimulated glucose transport in cultured cardiomyocytes.
FAK activity is essential for glucose transport stimulation in cardiomyocytes, and its downregulation by free fatty acids contributes to impaired metabolic responsiveness.
FAK may mediate FFA-induced glucose transport defects in cardiomyocytes; leaves open therapeutic targeting in metabolic heart disease.
Stimulation of glucose transport is markedly impaired in cardiomyocytes exposed to free fatty acids (FFA), despite relative preservation of canonical insulin- or metabolic stress signaling. We determined whether Focal Adhesion Kinase (FAK) activity is required for stimulation of glucose transport in cardiomyocytes, and whether FAK downregulation participates in FFA-induced impairment of glucose transport stimulation. Glucose transport, measured in isolated cultured cardiomyocytes, was acutely stimulated either by insulin treatment, or by metabolic inhibition with oligomycin resulting in AMP-activated kinase (AMPK) activation. FAK activity was inhibited pharmacologically by preincubation with PF-573,228 (PF). FAK activity was assessed from its autophosphorylation on residue Y397, and from the phosphorylation of its target paxillin on Y118. Y397 FAK phosphorylation was reduced in cultured cardiomyocytes chronically exposed to FFA. Preincubation with PF prior to determination of glucose transport resulted in a significant reduction of oligomycin-stimulated glucose transport, with a lesser reduction in insulin-stimulated glucose transport. Insulin and AMPK signaling was unaffected by PF preincubation. siRNA-mediated FAK knockdown also resulted in reduced oligomycin-stimulated glucose transport. Chronic treatment of FFA-exposed cardiomyocytes with phenylephrine or a phorbol ester restored FAK activity and improved glucose transport. In conclusion, stimulation of glucose transport in cardiomyocytes requires FAK activity prior to stimulation. The chronic reduction of FAK activity in cardiomyocytes exposed to FFA contributes to the loss of glucose transport responsiveness to insulin or metabolic inhibition. J. Cell. Biochem. 118: 670-677, 2017.
No takes yet. Share an insight, caveat, or question.
Viglino et al. (2016) studied this question. FAK inhibition (PF-573,228 or siRNA) vs. Control was evaluated on Glucose transport. Pharmacological or siRNA-mediated inhibition of FAK significantly reduced oligomycin- and insulin-stimulated glucose transport in cultured cardiomyocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: